Recent studies have demonstrated that Gas6 amplifies vascular dysfunction by promoting endothelin-1 expression, a potent vasoconstrictor, while simultaneously reducing nitric oxide (NO) bioavailability, leading to increased vascular resistance and hypertension. The gene discussed is GAS6; the disease is hypertensive disorder.